On this episode of CANCER BUZZ, learn why a trip to the emergency department is different for patients who receive immunotherapy for cancer, what information helps ED clinicians, and what busy emergency departments providers need to know about immune-related adverse events in patients treated with checkpoint inhibitors.

Guest:

• Sarah Dubbs, MD, Assistant Professor in Emergency Medicine; Assistant Director of the Emergency Medicine Residency Program, University of Maryland School of Medicine

Relevant Content:

• IO Wallet Card, by the ACCC Immuno-Oncology Institute
• “IO Patients in the Emergency Department,” by Junaid Razzak, MBBS, MD, PhD
• “Communication: Key to Addressing Toxicity and Recurrence Risks,” by Mark B. Faries, MD
• “Immunotherapy Complications in the Emergency Department,” by Adarsh Srivastava, MD, American Academy of Emergency Medicine
• “Management of Immune Checkpoint Inhibitor Toxicities: A Review and Clinical Guideline for Emergency Physicians,” by Adam T. Hryniewicki et al.
• “Pseudoprogression in Patients Treated with Immunotherapy,” by Ryan M. Weight, DO, MS

The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.